Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

SMMT

Summit Therapeutics Inc

Mar 03 • 12:43PM ET

20.30

Dollar change -0.39
Percentage change -1.88	%

Healthcare • Biotechnology • USA • NASD

Peers: VRTX REGN GILD NBIX ALNY BIIB AMGN SRPT AKTX PRTA

| Held by: VTI XBI VB VXF IWM VBR IWO SCHA IBB VHT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.31	Insider Own	84.42%	Shs Outstand	737.63M	Perf Week	7.75%
Market Cap	14.97B	Forward P/E	-	EPS next Y	-0.62	Insider Trans	0.00%	Shs Float	114.92M	Perf Month	-9.21%
Income	-221.31M	PEG	-	EPS next Q	-0.10	Inst Own	12.62%	Short Float	18.66%	Perf Quarter	5.73%
Sales	0.00M	P/S	-	EPS this Y	-38.25%	Inst Trans	9.49%	Short Ratio	9.03	Perf Half Y	54.73%
Book/sh	0.53	P/B	38.52	EPS next Y	-45.44%	ROA	-69.32%	Short Interest	21.45M	Perf Year	348.12%
Cash/sh	0.56	P/C	36.29	EPS next 5Y	-28.86%	ROE	-94.89%	52W Range	2.10 - 33.89	Perf YTD	13.76%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-10.52%	ROI	-56.43%	52W High	-40.10%	Beta	-1.04
Dividend TTM	-	Quick Ratio	10.15	Sales past 5Y	-8.94%	Gross Margin	-	52W Low	866.67%	ATR (14)	1.72
Dividend Ex-Date	-	Current Ratio	10.15	EPS Y/Y TTM	80.00%	Oper. Margin	-	RSI (14)	50.05	Volatility	11.53% 8.29%
Employees	159	Debt/Eq	0.02	Sales Y/Y TTM	-100.00%	Profit Margin	-	Recom	1.00	Target Price	36.29
Option/Short	Yes / Yes	LT Debt/Eq	0.01	EPS Q/Q	-59.00%	Payout	-	Rel Volume	0.84	Prev Close	20.69
Sales Surprise	-	EPS Surprise	2.20%	Sales Q/Q	-	Earnings	Feb 24 BMO	Avg Volume	2.38M	Price	20.30
SMA20	-0.27%	SMA50	1.96%	SMA200	28.33%	Trades		Volume	1,043,388	Change	-1.88%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-28-25	Initiated	Goldman	Buy	$42
Jan-08-25	Initiated	Truist	Buy	$35
Dec-11-24	Initiated	Wells Fargo	Overweight	$30
Dec-06-24	Initiated	Jefferies	Buy	$31
Nov-04-24	Initiated	JMP Securities	Mkt Outperform	$32
Sep-27-24	Downgrade	Citigroup	Buy → Neutral	$19 → $23
Aug-12-24	Initiated	H.C. Wainwright	Buy	$16
May-07-24	Initiated	Citigroup	Buy	$7
Mar-26-24	Initiated	Stifel	Buy	$8
Jun-28-18	Downgrade	Janney	Buy → Neutral
May-02-18	Initiated	Janney	Buy
Apr-12-18	Reiterated	Needham	Buy	$30 → $27
Feb-13-18	Initiated	BTIG Research	Buy	$33
Jan-04-18	Initiated	SunTrust	Buy	$24
Dec-01-17	Resumed	H.C. Wainwright	Buy	$16
Nov-16-16	Reiterated	RBC Capital Mkts	Outperform	$26 → $29
Oct-05-16	Reiterated	Needham	Buy	$22 → $30
Sep-16-16	Initiated	H.C. Wainwright	Buy	$26
Mar-30-15	Initiated	Oppenheimer	Outperform	$28
Mar-30-15	Initiated	Needham	Buy	$22

Show Previous Ratings

Feb-27-25 01:14PM	Summit Therapeutics Inc. (SMMT): Among the Stocks That Will Go to the Moon According to Analysts (Insider Monkey)
Feb-25-25 11:17AM	Why Summit Therapeutics Inc. (SMMT) Went Down On Monday? (Insider Monkey)
03:56AM	Q4 2024 Summit Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
02:01AM	Summit Therapeutics Inc (SMMT) Q4 2024 Earnings Call Highlights: Strong Financial Position and ... (GuruFocus.com)
Feb-24-25 12:52PM	Pfizer sets sights on Summits bispecific in combo with its ADCs (Pharmaceutical Technology) -14.83%
12:43PM	Loading…
12:43PM	Is Summit Therapeutics (SMMT) One of the Best Growth Stocks to Invest In According to Analysts? (Insider Monkey)
10:13AM	Summit Therapeutics Stock Sinks as Firm Reports Widening Loss (Investopedia)
06:05AM	Summit Therapeutics Reports Financial Results and Operational Progress for the Fourth Quarter and Twelve Months Ended December 31, 2024 (Business Wire)
06:00AM	Summit Therapeutics Announces Clinical Trial Collaboration with Pfizer to Evaluate Ivonescimab in Combination with Pfizer Antibody Drug Conjugates (ADCs) (Business Wire)
Feb-18-25 09:00AM	Summit Therapeutics to Host Fourth Quarter and Full Year 2024 Financial Results & Operational Progress Call on February 24, 2025 (Business Wire)
Feb-17-25 04:32AM	3 Stocks That Could Trounce the Market in 2025 (Motley Fool)
Feb-14-25 04:15PM	Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Feb-09-25 06:15AM	Is Summit Therapeutics a Millionaire Maker? (Motley Fool)
Feb-08-25 09:01AM	Why Summit Therapeutics Inc. (SMMT) Is Among the Best Healthcare Stocks To Buy According to Analysts (Insider Monkey)
08:50AM	2 Stocks That Could Soar Again in 2025 (Motley Fool)
05:30AM	Loading…
Feb-07-25 05:30AM	The Drug Industry Is Having Its Own DeepSeek Moment (The Wall Street Journal)
Feb-03-25 01:11PM	Summit Therapeutics (SMMT): Jim Cramer Calls It a Very Big Spec (Insider Monkey) -7.07%
Jan-30-25 09:15AM	Up More Than 500% in 12 Months, Is It Too Late to Buy Summit Therapeutics Stock? (Motley Fool)
Jan-29-25 03:58PM	Is Summit Therapeutics Inc. (SMMT) the Unstoppable Stock to Buy in 2025? (Insider Monkey) -7.91%
Jan-26-25 02:40AM	Why Summit Therapeutics (SMMT) Is Skyrocketing Now (Insider Monkey)
Jan-23-25 05:47AM	3 Unstoppable Stocks to Buy That Wall Street Thinks Will Soar More Than 35% (Motley Fool)
Jan-21-25 12:06PM	Why Summit Therapeutics Stock Is Jumping Today (Motley Fool) +16.13%
Jan-20-25 07:00PM	Heres Why Analysts Are Bullish on Summit Therapeutics Inc. (SMMT) (Insider Monkey)
Jan-18-25 05:52PM	Is Summit Therapeutics (SMMT) the Best Russell 2000 Stock to Invest in According to Analysts? (Insider Monkey)
Jan-16-25 04:15PM	Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Jan-15-25 09:35AM	Why Summit Therapeutics Rocketed 584% in 2024 (Motley Fool) +9.31%
Jan-07-25 07:00AM	Summit Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference (Business Wire)
Jan-04-25 06:48AM	Prediction: These 3 Healthcare Stocks Will Soar in 2025 (Motley Fool)
Jan-01-25 12:45PM	Why Is Summit Therapeutics Inc. (SMMT) Among the Best Multibagger Stocks to Buy Right Now? (Insider Monkey)
Dec-29-24 06:47AM	3 Stocks That Could Be Monster Winners in 2025 (Motley Fool)
10:36AM	Loading…
Dec-23-24 10:36AM	Is Summit Therapeutics Inc. (SMMT) the Best Performing Biotech Stock in 2024? (Insider Monkey)
Dec-20-24 10:21AM	Why Did Summit Therapeutics Inc. (SMMT) Jump Yesterday? (Insider Monkey)
06:30AM	Where Will Summit Therapeutics Be in 5 Years? (Motley Fool)
04:50AM	3 Stocks That Could Turn $1,000 into $5,000 by 2030 (Motley Fool)
Dec-18-24 05:44AM	3 No-Brainer Biotech Stocks to Buy With $200 Right Now (Motley Fool) -8.56%
Dec-15-24 07:37AM	2 Soaring Stocks That Could Climb 68% to 166% Higher in 2025, According to Wall Street (Motley Fool)
Dec-14-24 04:00PM	Investing $5,000 in Each of These 3 Stocks at the Start of 2024 Would Have Created a Portfolio Worth More Than $100,000 Today (Motley Fool)
Dec-13-24 04:15PM	Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Dec-06-24 07:09PM	Why Summit Therapeutics Stock Rocketed 6% Higher on Friday (Motley Fool) +5.82%
Dec-02-24 04:22AM	Billionaire Ken Griffin Is Selling Palantir and Buying a Stock Wall Street Expects to Rocket 139% Higher (Motley Fool)
Nov-30-24 06:05AM	Warning: This Skyrocketing Stock Has a Hidden Risk (Motley Fool)
Nov-26-24 04:15PM	Summit Therapeutics to Present at Upcoming Investor Conferences (Business Wire)
Nov-23-24 06:30AM	3 Monster Stocks in the Making (Motley Fool)
Nov-21-24 04:15PM	Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Nov-20-24 08:27AM	Summit Therapeutics (SMMT) Hurt Bronte Capital. Heres Why (Insider Monkey) -6.90%
Nov-14-24 04:54PM	Merck Spends Up To $3.3 Billion In An Insurance Policy Against Summit Therapeutics (Investor's Business Daily) -5.86%
Nov-10-24 06:26PM	TipRanks Perfect 10 Picks: 2 Top-Scoring Stocks for the Rest of 2024 (TipRanks)
Nov-08-24 07:00AM	2 Hot Biopharma Stocks to Buy and Hold for 5 Years (Motley Fool)
Nov-04-24 06:56PM	Why Summit Therapeutics Stock Was a Winner Today (Motley Fool) +5.11%
02:14PM	Summit Therapeutics 'Unique Investment In Oncology,' Lead Drug Candidate Shows Promise Over Keytruda And Opdivo (Benzinga)
01:43PM	Summit Therapeutics Leads the Parade of Big Gainers (GuruFocus.com)
Nov-03-24 06:41AM	3 Magnificent Stocks Under $100 to Buy in November (Motley Fool)
Oct-31-24 08:29AM	3 Stocks That Have Generated 1,000% Returns in Just 2 Years (Motley Fool)
07:01AM	Summit Therapeutics Inc (SMMT) Q3 2024 Earnings Call Highlights: Strategic Advances and ... (GuruFocus.com)
01:06AM	Decoding Summit Therapeutics Inc (SMMT): A Strategic SWOT Insight (GuruFocus.com)
Oct-30-24 07:00AM	Summit Therapeutics Reports Operational Progress and Financial Results for the Third Quarter and Nine Months Ended September 30, 2024 (Business Wire) -14.57%
Oct-27-24 02:29PM	Is Summit Therapeutics a Millionaire Maker? (Motley Fool)
09:14AM	Summit Therapeutics Inc. (SMMT): An Unstoppable Stock That Could Make You Richer (Insider Monkey)
Oct-24-24 05:13AM	Up Over 600% in 2024, Can Summit Therapeutics Stock Keep Rising? (Motley Fool)
Oct-23-24 04:15PM	Summit Therapeutics to Host Third Quarter 2024 Financial Results & Operational Progress Call on October 30, 2024 (Business Wire)
Oct-22-24 07:00AM	Billionaire Israel Englander Just Quietly Took a Stake in This Potentially Lucrative Pharmaceutical Stock. Should You? (Motley Fool)
Oct-20-24 02:23PM	Is Summit Therapeutics Inc. (SMMT) the Best QQQ Stock to Buy According to Analysts? (Insider Monkey)
Oct-15-24 06:30AM	Up 700% This Year, Is It Too Late to Invest in This Stock? (Motley Fool) +7.85%
Oct-13-24 12:11PM	Better Biotech Stock to Buy With $1,500 Right Now: Viking Therapeutics vs. Summit Therapeutics (Motley Fool)
Oct-12-24 09:15AM	3 Things You Need to Know If You Buy Summit Therapeutics Stock Today (Motley Fool)
Oct-09-24 05:04PM	Summit Therapeutics Inc (SMMT) Q2 2024 Earnings Call Highlights: Strategic Advances and ... (GuruFocus.com)
Oct-07-24 05:29AM	2 Soaring Stocks That Could Climb Another 112% and 120%, According to Wall Street Analysts (Motley Fool)
Oct-06-24 09:39AM	Summit Therapeutics Inc. (SMMT): Hedge Funds Are Bullish On This NASDAQ Stock Right Now (Insider Monkey)
Oct-05-24 11:12AM	Is Summit Therapeutics a Millionaire Maker? (Motley Fool)
Oct-04-24 04:15PM	Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
09:41AM	Summit Therapeutics Stock Jumps as Lung Cancer Drug Placed on FDA Fast Track (Investopedia)
07:45AM	Could Summit Therapeutics Become the Next Merck? (Motley Fool)
07:01AM	Is Summit Therapeutics Inc. (SMMT) the Best High Short Interest Stock to Invest In Now? (Insider Monkey)
04:32AM	Summit completes subject enrolment in Phase III NSCLC treatment trial (Clinical Trials Arena)
Oct-03-24 04:15PM	Summit Therapeutics Announces Completion of Enrollment in Its Phase III HARMONi Trial in 2L+ EGFRm NSCLC (Business Wire)
09:00AM	Where Will Summit Therapeutics Be in 3 Years? (Motley Fool)
Oct-02-24 08:15AM	Has Summit Therapeutics Stock Already Peaked? (Motley Fool)
Sep-30-24 06:28AM	Is Summit Therapeutics Stock a Buy? (Motley Fool)
Sep-29-24 07:30AM	2 High-Potential Growth Stocks You Shouldn't Overlook (Motley Fool)
Sep-28-24 07:03AM	Better Rising Biotech: Viking Therapeutics vs. Summit Therapeutics (Motley Fool)
Sep-26-24 01:23AM	Is Summit Therapeutics Inc. (SMMT) the Best Performing Stock in 2024? (Insider Monkey)
Sep-25-24 04:56AM	2 Stocks Up Over 700% in 2024 That Could Soar Even Further (Motley Fool) -5.67%
Sep-23-24 07:00AM	How a Surfer Who Never Finished College Became a Biotech Billionaire (The Wall Street Journal) -10.17%
Sep-22-24 04:15PM	This Stock Is Crushing Nvidia's Performance This Year: Is It Too Late to Buy? (Motley Fool)
Sep-20-24 07:53AM	Keytruda beaten by Summits bispecific in NSCLC (Clinical Trials Arena) +5.31%
Sep-19-24 12:02PM	BioNTech Is More Than a Covid-19 Stock. Its Having a Great September. (Barrons.com) -5.70%
05:50AM	Is It Too Late to Buy Summit Therapeutics Stock After Its Almost 10X Gain This Year? (Motley Fool)
Sep-18-24 09:53AM	This Company Generates No Revenue and Its Market Cap Is Over $20 Billion. Here's Why That Valuation May Not Be All That Ridiculous. (Motley Fool) -6.33%
Sep-17-24 04:09PM	How BioNTech, Up 26% Over Four Days, Is Riding Summit's Coattails To A Recovery (Investor's Business Daily) -11.06%
04:24AM	Here's Why Everyone's Talking About Summit Therapeutics (Motley Fool)
Sep-16-24 06:30AM	Promising Anti-Tumor Activity and Safety of Ivonescimab in Combination Therapies in CRC, TNBC, and HNSCC Featured at ESMO 2024 (Business Wire) -7.67%
Sep-14-24 11:44AM	Is Summit Therapeutics Inc. (NASDAQ:SMMT) an Unstoppable Growth Stock To Buy Now? (Insider Monkey)
Sep-13-24 10:30AM	Why Summit Therapeutics Skyrocketed 123% This Week (Motley Fool) +16.49%
Sep-12-24 04:06PM	Summit Therapeutics, With 85% Gain This Week, Rockets Again On $235 Million Sale (Investor's Business Daily) +20.75%
11:53AM	Why Summit Therapeutics Stock Is Soaring Again Today (Motley Fool)
06:30AM	Summit Therapeutics Raises $235 Million (Business Wire)
Sep-11-24 07:08PM	Summit Therapeutics Co-CEOs on what's next for lung cancer drug (CNBC TV)
Sep-10-24 04:27AM	Is Summit Therapeutics a Buy Now? (Motley Fool) +20.01%
Sep-09-24 04:11PM	Merck Dives After Summit Up 56% Sneaks In With Keytruda-Walloping Punch (Investor's Business Daily) +55.99%
02:01PM	Why Summit Therapeutics Rocketed Over 60% Today (Motley Fool)

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Zanganeh Mahkam	Chief Executive Officer	Mar 27 '24	Buy	3.72	54,321	201,874	24,923,800	Mar 27 08:28 PM
Zanganeh Mahkam	Chief Executive Officer	Mar 26 '24	Buy	3.75	30,000	112,500	30,000	Mar 27 08:28 PM
Zanganeh Mahkam	Chief Executive Officer	Mar 27 '24	Buy	3.72	26,000	96,720	520,814	Mar 27 08:28 PM
Dhingra Ankur	Chief Financial Officer	Mar 26 '24	Buy	3.75	100,000	375,000	354,958	Mar 27 08:27 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

SMMT

Summit Therapeutics Inc

Upgrade your FINVIZ experience